BofA raised the firm’s price target on Synovus (SNV) to $60 from $59 and keeps a Buy rating on the shares. The company reported a Q1 earnings beat and solid update, the analyst tells investors in a research note. The firm sees a discounted valuation for the shares relative to Synovus’ growth potential.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNV:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue